Exagen Inc (XGN) financials · rev $66.6M
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Exagen Inc (XGN) rev $66.6M.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $66.6M | $55.6M |
| Cost of Revenue | $27.8M | $22.5M |
| Gross Profit | $38.8M | $33.1M |
| Operating Income | -$14.1M | -$13.6M |
| Net Income | -$20.0M | -$15.1M |
| EPS (Diluted) | -$0.93 | -$0.83 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $58.0M | $44.7M |
| Current Assets | $48.9M | $36.5M |
| Cash & Equivalents | $32.2M | $22.0M |
| Total Liabilities | $40.6M | $35.1M |
| Current Liabilities | $14.2M | $13.5M |
| Short-term Debt | $643.0K | $423.0K |
| Long-term Debt | $22.3M | $19.8M |
| Total Debt | $22.9M† | $20.2M† |
| Shareholders' Equity | $17.4M | $9.54M |
| Retained Earnings | -$314.3M | -$294.3M |
† Total Debt: Derived: short-term debt plus long-term debt (no total debt stored).
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | -$13.6M | -$13.3M |
| CapEx | $641.0K | $515.0K |
| Investing Cash Flow | -$626.0K | -$515.0K |
| Financing Cash Flow | $24.4M | -$663.0K |
| Net Change in Cash | $10.2M | -$14.5M |
| Free Cash Flow | -$14.3M | -$13.8M |
FAQ
What is XGN P/E and revenue?
Exagen Inc (XGN) rev $66.6M.
What is XGN revenue?
Exagen Inc last cached revenue is $66.6M (FY2025).
Is XGN profitable?
Exagen Inc last cached net income is -$20.0M (FY2025).
What are XGN total assets?
Exagen Inc last cached total assets are $58.0M (FY2025).
What is XGN free cash flow?
Exagen Inc last cached free cash flow is -$14.3M (FY2025).
Not investment advice. Cached statements, not a live tape.